Delivery Order SPE2DB20D2104-SPE2DB25FMRCS
Award Date
5/16/25
Potential Completion Date
5/19/25
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 30 MG TABLET, a pharmaceutical product. The contract has a ceiling value of $18,842.90 and a completion date of June 5, 2025. It is a Firm Fixed Price contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is valued at $12,525.32 and will run through September 10, 2024. It involves the delivery of the prescription medication RINVOQ ER 15 MG TABLET. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999, for providing...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication RINVOQ ER 15 MG TABLET in units of 30, with a ceiling value of $11,240.90. The contract is a firm fixed-price, non-set-aside agreement with a completion date of May 13, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15 MG TABLET, a medication, with a ceiling value of $12,337.48 and a period of performance through June 4, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has a firm fixed price, a ceiling value of $12,153.60, and a period of performance through June 24, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $3,878.55, is for the supply of the prescription drug RINVOQ ER 15 MG TABLET. The contract has a firm fixed price and an ultimate completion date of September 5, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15MG TAB 30S, a prescription medication, with a ceiling value of $9,334.95 and a performance period through May 14, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,820.45, is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has a final completion date of May 13, 2024 and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15 MG TABLET, a medication used to treat certain medical conditions. The contract has a firm fixed price, a ceiling value of $3,233.89, and a completion date of May 16, 2025. This delivery order is not set aside and represents open competition. Amerisourcebergen Drug Corp...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15 MG TABLET, a prescription medication, with a ceiling value of $11,047.13 and a period of performance through May 19, 2025. This order is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a...